RD
Rajalingam Dyavanapalli
About Rajalingam Dyavanapalli
Data last updated:
Rajalingam Dyavanapalli is a Director at Mark Drugs Limited (since 1995). The companies operate in Pharma. Earlier, Rajalingam Dyavanapalli was a Director at Manasa Build Tech (India) Private Limited (from 2008).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Mark Drugs Limited U24239TG1995PLC019228 | Director | 18 Jan 1995 | 1995 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Manasa Build Tech (India) Private Limited U45200TG2008PTC058931 | Director | 30 Apr 2008 | 2008 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Rajalingam Dyavanapalli
| Name | DIN | Company | Designation |
|---|---|---|---|
| Anandam Dyavanapally | 02037483 | Mark Drugs Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rajalingam Dyavanapalli
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rajalingam Dyavanapalli
Rajalingam Dyavanapalli currently holds 1 directorship: Mark Drugs Limited (Director, since 18 Jan 1995).
Rajalingam Dyavanapalli was first appointed on 18 Jan 1995 as Director at Mark Drugs Limited. The most recent appointment on record is 30 Apr 2008 at Manasa Build Tech (India) Private Limited.
Rajalingam Dyavanapalli held 1 earlier board appointment: Manasa Build Tech (India) Private Limited (Director, from 30 Apr 2008).
The current boards of Rajalingam Dyavanapalli's companies include Anandam Dyavanapally (Mark Drugs Limited).